Association of Coffee and Caffeine Intake With the Risk of Parkinson Disease

Regression Models and Life-Tables

Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793

Regression Models and Life-Tables

Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297

Parkinson's Disease

Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,072

Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects

Nehlig, A., Daval, J., & Debry, G. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90012-b · Cited by 1,463

Parkinson Disease in Twins

Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R. P., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 876

Epidemiology of parkinson’s disease

Tanner, C. M., & Goldman, S. M. (1996) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70259-0 · Cited by 640

Coffee, Alcohol and Risk of Coronary Heart Disease among Japanese Men Living in Hawaii

Yano, K., Rhoads, G. G., & Kagan, A. (1977) · New England Journal of Medicine · doi:10.1056/nejm197708252970801 · Cited by 524

Prevalence of Dementia in Older Japanese-American Men in Hawaii: The Honolulu-Asia Aging Study

White, L. (1996) · JAMA · doi:10.1001/jama.1996.03540120033030 · Cited by 437

TEN-YEAR INCIDENCE OF CORONARY HEART DISEASE IN THE HONOLULU HEART PROGRAM

Yano, K., REED, D. M., & McGee, D. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113787 · Cited by 370

Worldwide Occurrence of Parkinson's Disease: An Updated Review

Zhang, Z., & Román, G. C. (1993) · Neuroepidemiology · doi:10.1159/000110318 · Cited by 332

Effects of different decaffeination methods on caffeine contents, physicochemical, and sensory properties of coffee

Shofinita, D., Lestari, D., Purwadi, R., Sumampouw, G. A., Gunawan, K. C., Ambarwati, S. A., Achmadi, A. B., & Tjahjadi, J. T. (2024) · International Journal of Food Engineering · doi:10.1515/ijfe-2024-0013 · Cited by 22

cAMP-Inhibits Cytoplasmic Phospholipase A2 and Protects Neurons against Amyloid-β-Induced Synapse Damage

Bate, C., & Williams, A. (2015) · Biology · doi:10.3390/biology4030591 · Cited by 22

Development and application of nano-flavor-drug carriers in neurodegenerative diseases

Ji, W., Xiao, Z.-B., Liu, G., & Zhang, X. (2017) · Chinese Chemical Letters · doi:10.1016/j.cclet.2017.06.024 · Cited by 22

Nutrition and the risk for Parkinson’s disease: review of the literature

Gaenslen, A., Gasser, T., & Berg, D. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-007-0005-4 · Cited by 23

Coffee and Cigarette Consumption and Perceived Effects in Recovering Alcoholics Participating in Alcoholics Anonymous in Nashville, Tennessee

Reich, M. S., Dietrich, M. S., Finlayson, A. J. R., Fischer, E. F., & Martin, P. R. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00751.x · Cited by 23

Systematic analysis of the molecular mechanisms mediated by coffee in Parkinson’s disease based on network pharmacology approach

Li, F., Hatano, T., & Hattori, N. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104764 · Cited by 21

Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases

Xiang, Y., Naik, S. G., Zhao, L., Shi, J., & Ke, H. (2024) · Medicinal Research Reviews · doi:10.1002/med.22017 · Cited by 21

Interaction of caffeine and sulfadiazine with lysozyme adsorbed at colloidal metal nanoparticle interface: influence on drug transport ability and antibacterial activity

Sonu, V. K., Singh, I. R., Bhattacharjee, K., Joshi, S. R., & Mitra, S. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1426497 · Cited by 21

Excessive daytime sleepiness and topographic expansion of Lewy pathology

Abbott, R. D., Ross, G. W., Duda, J. E., Shin, C., Uyehara‐Lock, J. H., Masaki, K., Launer, L. J., White, L. R., Tanner, C. M., & Petrovitch, H. (2019) · Neurology · doi:10.1212/wnl.0000000000008241 · Cited by 22

History of Parkinson's disease

Goldman, J. G., & Goetz, C. G. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83005-3 · Cited by 21

Differences in Parkinson’s Disease Risk with Caffeine Intake and Postmenopausal Hormone Use

Kim, I. Y., O’Reilly, É. J., Hughes, K. C., Gao, X., Schwarzschild, M. A., & Ascherio, A. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171175 · Cited by 21

Parkinson's Disease: Genetics and Pathogenesis

Testa, C. M. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn063 · Cited by 21

Glutathione-Mediated Neuroprotective Effect of Purine Derivatives

Matsumura, N., & Aoyama, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713067 · Cited by 21

Differential effects of age on human striatal adenosine A1and A2Areceptors

Mishina, M., Kimura, Y., Naganawa, M., Ishii, K., Oda, K., Sakata, M., Toyohara, J., Kobayashi, S., Katayama, Y., & Ishiwata, K. (2012) · Synapse · doi:10.1002/syn.21573 · Cited by 20

Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer’s Disease and Parkinson’s Disease

Tapias, V., González-Andrés, P., Fernández-Peña, L., Barbero, A., Núñez, L., & Villalobos, C. (2023) · Antioxidants · doi:10.3390/antiox12061282 · Cited by 21

Management of patients with Parkinson disease

Shin, J. Y., & Hendrix, C. C. (2013) · The Nurse Practitioner · doi:10.1097/01.npr.0000434090.96229.5c · Cited by 20

Comparison of Environmental and Genetic Factors for Parkinson’s Disease between Chinese and Caucasians

Chan, D. K. Y., Cordato, D. J., Bui, T., Mellick, G. D., & Woo, J. (2004) · Neuroepidemiology · doi:10.1159/000073970 · Cited by 20

Adenosine A2A antagonists: potential preventive and palliative treatment for Parkinson's disease

Morelli, M. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00316-9 · Cited by 20

Smoking, alcohol, and coffee consumption preceding Parkinson’s disease

Deleu, D. (2001) · Neurology · doi:10.1212/wnl.56.7.984-a · Cited by 20

Targeting the adenosine A2A receptor for neuroprotection and cognitive improvement in traumatic brain injury and Parkinson's disease

Zhao, Y., Zhou, Y., & Chen, J. (2023) · Chinese Journal of Traumatology · doi:10.1016/j.cjtee.2023.08.003 · Cited by 21

The Coffee–Acrylamide Apparent Paradox: An Example of Why the Health Impact of a Specific Compound in a Complex Mixture Should Not Be Evaluated in Isolation

Nehlig, A., & Cunha, R. A. (2020) · Nutrients · doi:10.3390/nu12103141 · Cited by 19

Binding of the Antagonist Caffeine to the Human Adenosine Receptor hA2AR in Nearly Physiological Conditions

Cao, R., Rossetti, G., Bauer, A., & Carloni, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126833 · Cited by 19

A Tail of Two Signals: The C Terminus of the A2A-Adenosine Receptor Recruits Alternative Signaling Pathways

Gsandtner, I., & Freissmuth, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026757 · Cited by 18

Cohort studies in health sciences librarianship.

Eldredge, J. D. (2002) · Europe PMC (PubMed Central) · Cited by 19

Cross-sensitization between caffeine- and l-dopa-induced behaviors in hemiparkinsonian mice

Yu, L., Schwarzschild, M. A., & Chen, J. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.09.036 · Cited by 19

Caffeine as a Neuroprotective Adenosine Receptor Antagonist

Dall'Igna, O. P. P., Souza, D. O., & Lara, D. R. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d307 · Cited by 19

Literature-Related Discovery (LRD)

Kostoff, R. N., Block, J. A., Solka, J. L., Briggs, M. B., Rushenberg, R. L., Stump, J. A., Johnson, D., Lyons, T. J., & Wyatt, J. R. (2007) · Defense Technical Information Center (DTIC) · doi:10.21236/ada473438 · Cited by 19

Indanone: a promising scaffold for new drug discovery against neurodegenerative disorders

Bansal, R., Singh, R., Dutta, T. S., Dar, Z. A., & Bajpai, A. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104063 · Cited by 18

Espresso Coffee Mitigates the Aggregation and Condensation of Alzheimer′s Associated Tau Protein

Tira, R., Viola, G., Barracchia, C. G., Parolini, F., Munari, F., Capaldi, S., Assfalg, M., & D’Onofrio, M. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c01072 · Cited by 18

In vivo evaluation of [123I]MNI-420: A novel single photon emission computed tomography radiotracer for imaging of adenosine 2A receptors in brain

Tavares, A., Batis, J. C., Barret, O., Alagille, D., Vala, C., Kudej, G., Koren, A. O., Cosgrove, K., Nice, K., Kordower, J. H., et al. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.12.005 · Cited by 18

Kinetic Modeling, Test–Retest, and Dosimetry of 123I-MNI-420 in Humans

Tavares, A., Batis, J. C., Papin, C., Jennings, D. L., Alagille, D., Russell, D., Vala, C., Lee, H. S., Baldwin, R. M., Zubal, I. G., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.119933 · Cited by 18

Polymorphism and disorder in natural active ingredients. Low and high-temperature phases of anhydrous caffeine: Spectroscopic (1H–14N NMR–NQR/14N NQR) and solid-state computational modelling (DFT/QTAIM/RDS) study

Seliger, J., Žagar, V., Apih, T., Gregorovič, A., Latosińska, M., Olejniczak, G. A., & Latosińska, J. N. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.01.025 · Cited by 18

Impaired mutagenic activities of MPDP+ (1-methyl-4-phenyl-2,3-dihydropyridinium) and MPP+ (1-methyl-4-phenylpyridinium) due to their interactions with methylxanthines

Ulanowska, K., Piosik, J., Gwizdek‐Wiśniewska, A., & Węgrzyn, G. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.05.025 · Cited by 18

Aromaticity of caffeine, xanthine and the dimethyl xanthines

Gibson, C. M., & Fowler, P. W. (2014) · Tetrahedron Letters · doi:10.1016/j.tetlet.2014.02.027 · Cited by 18

Adenosine A1receptors measured with11C-MPDX PET in early Parkinson's disease

Mishina, M., Ishii, K., Kimura, Y., Suzuki, M., Kitamura, S., Ishibashi, K., Sakata, M., Oda, K., Kobayashi, S., Kimura, K., et al. (2017) · Synapse · doi:10.1002/syn.21979 · Cited by 21

Methoxy substituted 2-benzylidene-1-indanone derivatives as A 1 and/or A 2A AR antagonists for the potential treatment of neurological conditions

van Rensburg, H. D. J., Legoabe, L. J., Terre’Blanche, G., & der Walt, M. M. V. (2019) · MedChemComm · doi:10.1039/c8md00540k · Cited by 18

Epigenetic modifications induced by exercise: Drug-free intervention to improve cognitive deficits associated with obesity

Barros, L., Eichwald, T., Solano, A. F., Scheffer, D. D. L., da Silva, R. A., Gaspar, J. M., & Latini, A. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.03.009 · Cited by 18

Gender-dependent effect of coffee consumption on tremor severity in de novo Parkinson’s disease

Cho, B., Choi, S., & Kim, B. C. (2019) · BMC Neurology · doi:10.1186/s12883-019-1427-y · Cited by 19

Living and dying with Parkinson's disease

Ross, G. W., & Abbott, R. D. (2014) · Movement Disorders · doi:10.1002/mds.25955 · Cited by 18

Complementary Therapies for Parkinson's Disease: What's Promoted, Rationale, Potential Risks and Benefits

Rabin, M., Stevens‐Haas, C., Havrilla, E., Rosenstein, A. K., Toffey, B., Devi, T., Earnhardt, M. C., & Kurlan, R. (2015) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12170 · Cited by 17

Norharman and harman in instant coffee and coffee substitutes

Alves, R. C., Mendes, E., Oliveira, M. B. P. P., & Casal, S. I. P. (2009) · Food Chemistry · doi:10.1016/j.foodchem.2009.11.070 · Cited by 17

Monoamine oxidase and α-synuclein as targets in Parkinson’s disease therapy

Follmer, C. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.920235 · Cited by 18

Possible Health Effects of Caffeinated Coffee Consumption on Alzheimer's Disease and Cardiovascular Disease

You, D.-C., Kim, Y. S., Ha, A. W., Lee, Y.-N., Kim, S.-M., Kim, C.-H., Lee, S.-H., Choi, D., & Lee, J. (2011) · Toxicological Research · doi:10.5487/tr.2011.27.1.007 · Cited by 17

Adjunctive preladenant: A placebo-controlled, dose-finding study in Japanese patients with Parkinson's disease

Hattori, N., Kikuchi, M., Adachi, N., Hewitt, D., Huyck, S. B., & Saito, T. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.08.020 · Cited by 17

The Association between Coffee and Tea Consumption at Midlife and Risk of Dementia Later in Life: The HUNT Study

Abbel, D., Åsvold, B. O., Kolberg, M., Selbæk, G., Noordam, R., & Skjellegrind, H. K. (2023) · Nutrients · doi:10.3390/nu15112469 · Cited by 16

Coffee, antioxidants, and brain inflammation

Rai, S. P., Ansari, A. H., Singh, D., & Singh, S. (2024) · Progress in brain research · doi:10.1016/bs.pbr.2024.06.005 · Cited by 20

GWAS of habitual coffee consumption reveals a sex difference in the genetic effect of the 12q24 locus in the Japanese population

Jia, H., Nogawa, S., Kawafune, K., Hachiya, T., Takahashi, S., Igarashi, M., Saito, K., & Kato, H. (2019) · BMC Genetics · doi:10.1186/s12863-019-0763-7 · Cited by 16

Dual actions of A2A adenosine receptor antagonists on motor dysfunction and neurodegenerative processes

Ongini, E., Monopoli, A., Impagnatiello, F., Fredduzzi, S., Schwarzschild, M. A., & Chen, J. (2001) · Drug Development Research · doi:10.1002/ddr.1137 · Cited by 16

Caffeine induces age-dependent increases in brain complexity and criticality during sleep

Thölke, P., Arcand-Lavigne, M., Lajnef, T., Frenette, S., Carrier, J., & Jerbi, K. (2025) · Communications Biology · doi:10.1038/s42003-025-08090-z · Cited by 15

Tea, coffee and associated lifestyle factors

Hewlett, P., & Wadsworth, E. J. K. (2012) · British Food Journal · doi:10.1108/00070701211213500 · Cited by 15

Parkinson’s Disease: Is there a Role for Dietary and Herbal Supplements?

Onaolapo, O. J., Odeniyi, A. O., & Onaolapo, A. Y. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210218082954 · Cited by 15

Apolipoprotein E Genotypes in Mexican Patients with Parkinson's Disease

Gallegos‐Arreola, M. P., Figuera, L. E., Ortiz, G. G., Jiménez-Gil, F. J., Ramírez-Vega, J., Ruíz‐Sandoval, J. L., Puebla‐Pérez, A. M., Troyo‐Sanromán, R., García‐Ortíz, J. E., Sánchez‐Corona, J., et al. (2009) · Disease Markers · doi:10.1155/2009/617863 · Cited by 15

Relationship between Nutrition, Lifestyle, and Neurodegenerative Disease: Lessons from ADH1B, CYP1A2 and MTHFR

Barati, S., Fabrizio, C., Strafella, C., Cascella, R., Caputo, V., Megalizzi, D., Peconi, C., Mela, J., Colantoni, L., Caltagirone, C., et al. (2022) · Genes · doi:10.3390/genes13081498 · Cited by 14

Marinesco bodies and substantia nigra neuron density in Parkinson's disease

Abbott, R. D., Nelson, J. S., Ross, G. W., Uyehara‐Lock, J. H., Tanner, C. M., Masaki, K., Launer, L. J., White, L. R., & Petrovitch, H. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12419 · Cited by 15

Aerobic Exercise and Healthy Nutrition as Neuroprotective Agents for Brain Health in Patients with Parkinson’s Disease: A Critical Review of the Literature

Cammisuli, D. M., Bonuccelli, U., Daniele, S., Martini, C., Fusi, J., & Franzoni, F. (2020) · Antioxidants · doi:10.3390/antiox9050380 · Cited by 17

Smoking exposure and Parkinson's disease: A UK Brain Bank pathology-validated case-control study

di Biase, L., Pecoraro, P. M., Carbone, S. P., Alessi, F., & Lazzaro, V. D. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.107022 · Cited by 14

Sources of variation of energy and nutrient intake among adolescents in São Paulo, Brazil

Verly, E., Fisberg, R. M., César, C. L. G., & Marchioni, D. M. L. (2010) · Cadernos de Saúde Pública · doi:10.1590/s0102-311x2010001100014 · Cited by 14

Biocatalytic Production and Purification of the High-value Biochemical Paraxanthine

Mock, M. B., Mills, S. B., Cyrus, A., Campo, H., Dreischarf, T., Strock, S., & Summers, R. M. (2022) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-021-0301-0 · Cited by 14

Coffee and its Active Compounds are Neuroprotective

Kim, J., & Lee, K. W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-409517-5.00046-2 · Cited by 14

Coffee–Functional Food and Medicinal Herb

Meletis, C. D. (2006) · Alternative and Complementary Therapies · doi:10.1089/act.2006.12.7 · Cited by 14

Adenosine 2A Receptor Antagonists for the Treatment of Motor Symptoms in Parkinson's Disease

Pourcher, E., & Huot, P. (2015) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12187 · Cited by 15

Higher systemic immune-inflammation index is associated with increased risk of Parkinson’s disease in adults: a nationwide population-based study

Zhao, J., Wu, Z., Cai, F., Yu, X., & Song, Z. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1529197 · Cited by 14

Suppression of Neuroinflammation by Coffee Component Pyrocatechol via Inhibition of NF-κB in Microglia

Murata, T., Tago, K., Miyata, K., Moriwaki, Y., Misawa, H., Kobata, K., Nakazawa, Y., Tamura, H., & Funakoshi‐Tago, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010316 · Cited by 17

International Journal for Pharmaceutical Research Scholars (IJPRS)

Thanikachalam, S., Chandrasekharan, A., Vijayakumar, H., Chidambaram, S., & Bhaskar, L. V. (2014) · Cited by 13

La cafeína como un fármaco preventivo de la enfermedad de Parkinson: evidencias epidemiológicas y sustrato experimental

Góngora-Alfaro, J. L. (2010) · Revista de Neurología · doi:10.33588/rn.5004.2009563 · Cited by 13

2–Benzylidene–1–Indanone Analogues as Dual Adenosine A1/A2a Receptor Antagonists for the Potential Treatment of Neurological Conditions

van Rensburg, H. D. J., Legoabe, L. J., Terre’Blanche, G., & der Walt, M. M. V. (2019) · Drug Research · doi:10.1055/a-0808-3993 · Cited by 13

Kahweol Exerts Skin Moisturizing Activities by Upregulating STAT1 Activity

Chen, H., Hossain, M. A., Kim, J., & Cho, J. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168864 · Cited by 13

Recent Studies on Nutrition and Parkinson’s Disease Prevention: A Systematic Review

Gaba, A. (2015) · Open Journal of Preventive Medicine · doi:10.4236/ojpm.2015.55023 · Cited by 14

Neuroprotection in Parkinson's Disease: A Systematic Review of the Preclinical Data

Douna, H., Bavelaar, B. M., Pellikaan, H., Olivier, B., & Pieters, T. (2012) · The Open Pharmacology Journal · doi:10.2174/1874143601206010012 · Cited by 13

Xanthine Derivatives as Agents Affecting Non-dopaminergic Neuroprotection in Parkinson’s Disease

Kasabova-Angelova, A., Tzankova, D., Mitkov, J., Georgieva, M., Tzankova, V., Zlatkov, A., & Kondeva-Burdina, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180821153316 · Cited by 13

Neuroprotection in Parkinson's Disease

Schapira, A. H. V. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00018-0 · Cited by 14

Cigarette smoking, coffee intake and alcohol consumption preceding Parkinson's disease: a case–control study

Grujičić, S. Š., Vlajinac, H., Maksimovic, J. M., Marinković, J., Dzoljic, E. D., Ratkov, I., & Kostić, V. S. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00593.x · Cited by 14

Role of Purines and Pyrimidines in the Central Nervous System

Masino, S. A., & Dunwiddie, T. V. (2001) · Springer eBooks · doi:10.1007/978-3-662-09604-8_9 · Cited by 13

Balance, mobility and falls in Parkinson’s disease

Matinolli, M. (2009) · Cited by 13

Air Pollutants and Risk of Parkinson’s Disease among Women in the Sister Study

Cao, Z., Yuan, Y., White, A. J., Li, C., Luo, Z., D’Aloisio, A. A., Huang, X., Kaufman, J. D., Sandler, D. P., & Chen, H. (2024) · Environmental Health Perspectives · doi:10.1289/ehp13009 · Cited by 12

Australian Parkinson’s Genetics Study (APGS): pilot (n=1532)

Bivol, S., Mellick, G. D., Gratten, J., Parker, R., Mulcahy, A., Mosley, P. E., Poortvliet, P. C., Campos, A. I., Mitchell, B. L., García‐Marín, L. M., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-052032 · Cited by 12

Coffee aroma constituents and odorant metabolites in human urine

Wagenstaller, M., & Buettner, A. (2013) · Metabolomics · doi:10.1007/s11306-013-0581-2 · Cited by 12

Caffeine Consumption Levels and Knowledge Among Adults in the United Arab Emirates: Insights from a Nationwide Survey

Hammami, M. B., Shaikh, Y. G. A., Hashem, A. M., Adi, O. M. M., Yaseen, I. A. A., Menawy, Z. M. E., & Elmoselhi, A. B. (2018) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2017.0034 · Cited by 12

Pharmacological Bases of Coffee Nutrients for Diabetes Prevention

Oka, K. (2007) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.127.1825 · Cited by 12

Narrative Review: Impact of Genetic Variability of CYP1A2 , ADORA2A , and AHR on Caffeine Consumption and Response

Tennent, R., Ali, A., Wham, C. A., & Rutherfurd-Markwick, K. J. (2020) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2020.0016 · Cited by 13

Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine

Góngora-Alfaro, J. L., Moo-Puc, R. E., Villanueva-Toledo, J. R., Álvarez-Cervera, F. J., Bata-García, J. L., Heredia-López, F. J., & Pineda, J. C. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.07.084 · Cited by 12

A Diet for Dopaminergic Neurons?

Giovanni, G. D. (2009) · Springer eBooks · doi:10.1007/978-3-211-92660-4_27 · Cited by 12

Prospects for the Development of Pink1 and Parkin Activators for the Treatment of Parkinson’s Disease

Blagov, A. V., Goncharov, A. G., Babich, O., Larina, V., Orekhov, A. N., & Melnichenko, A. А. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112514 · Cited by 11

Interaction between caffeine consumption & genetic susceptibility in Parkinson’s disease: A systematic review

Yang, Y., Zhou, Z., Yi, L., Tan, B. J., & Tan, E.-K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102381 · Cited by 13

Coffee's protective mechanisms against neurodegeneration

Raeis-Abdollahi, E., Raise‐Abdullahi, P., Rashidy‐Pour, A., Meamar, M., & Askari, H. (2024) · Progress in brain research · doi:10.1016/bs.pbr.2024.06.017 · Cited by 11

Does drug repurposing bridge the gaps in management of Parkinson’s disease? Unravelling the facts and fallacies

Bashir, B., Vishwas, S., Gupta, G., Paudel, K. R., Dureja, H., Kumar, P., Cho, H., Sugandhi, V. V., Kumbhar, P., Disouza, J., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102693 · Cited by 11

Profile of Nucleotide Catabolism and Ectonucleotidase Expression from the Hippocampi of Neonatal Rats After Caffeine Exposure

Silva, R. S. D., Richetti, S. K., Tonial, E. M., Bogo, M. R., & Bonan, C. D. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0577-0 · Cited by 11

Role of Adenosine A 2A Receptors in the Central Fatigue of Neurodegenerative Diseases

Alves, A. C. D. B., Bristot, V. J. D. O., Limana, M. D., Speck, A. E., Barros, L., Solano, A. F., & Aguiar, A. S. (2019) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2019.0009 · Cited by 12

Predicting Parkinson’s Disease and Its Pathology via Simple Clinical Variables

Karabayir, İ., Butler, L., Goldman, S. M., Kamaleswaran, R., Güntürkün, F., Davis, R. L., Ross, G. W., Petrovitch, H., Masaki, K., Tanner, C. M., et al. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212876 · Cited by 11

Tea and coffee powders

Huang, M., & Zhang, M. (2013) · Elsevier eBooks · doi:10.1533/9780857098672.3.513 · Cited by 11

Existing and emerging mitochondrial-targeting therapies for altering Parkinson's disease severity and progression

Pienaar, I. S., & Chinnery, P. F. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.010 · Cited by 11

La Enfermedad de Parkinson: Etiología, Tratamientos y Factores Preventivos

Hurtado, F., Cardenas, M. A. N., Cárdenas, F. P., & León, L. A. (2017) · Universitas Psychologica · doi:10.11144/javeriana.upsy15-5.epet · Cited by 11

α-Synuclein Aggregation and Parkinson’s Disease

Uversky, V. N. (2007) · Springer eBooks · doi:10.1007/978-0-387-36534-3_4 · Cited by 11

Dietary Caffeine and Brain Dopaminergic Function in Parkinson Disease

Saarinen, E. K., Kuusimäki, T., Lindholm, K., Niemi, K. J., Honkanen, E. A., Noponen, T., Seppänen, M., Ihalainen, T., Murtomäki, K., Mertsalmi, T. H., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26957 · Cited by 11

Coffee consumption and health

Petracco, M., & Viani, R. (2005) · Elsevier eBooks · doi:10.1016/b978-012370371-2/50011-1 · Cited by 10

Simultaneous administration of coffee and rasagiline/l-dopa protects against paraquat-induced neurochemical and motor behavior impairments in vivo

Aboutabl, M. E., Salman, A., el Din, A. A. G., & Maklad, Y. A. (2021) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-021-00678-9 · Cited by 10

Long-term outcomes from the UK Biobank on the impact of coffee on cardiovascular disease, arrhythmias, and mortality: Does the future hold coffee prescriptions?

Kotit, S. (2023) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2023.13 · Cited by 10

Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson’s disease patients and healthy controls

Wang, C., Zhou, C., Guo, T., Jiaerken, Y., Yang, S., Xu, X., Hu, L., Huang, P., Xu, X., & Zhang, M. (2023) · BMC Medicine · doi:10.1186/s12916-023-02994-5 · Cited by 10

The significance of goat milk in enhancing nutrition security: a scientiometric evaluation of research studies from 1966 to 2020

Idamokoro, E. (2023) · Agriculture & Food Security · doi:10.1186/s40066-023-00441-5 · Cited by 11

Caffeine intake enhances bowel recovery after colorectal surgery: a meta-analysis of randomized and non-randomized studies

Vaghiri, S., Prassas, D., David, S. O., Knoefel, W. T., & Krieg, A. H. (2024) · Updates in Surgery · doi:10.1007/s13304-024-01847-x · Cited by 10

Caffeine Intake, Smoking, and Risk of Parkinson Disease in Men and Women

Liu, R., Guo, X., Park, Y., Huang, X., Sinha, R. R., Freedman, N. D., Hollenbeck, A. R., Blair, A. E., & Chen, H. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr451 · Cited by 186

Differences in Parkinson’s Disease Risk with Caffeine Intake and Postmenopausal Hormone Use

Kim, I. Y., O’Reilly, É. J., Hughes, K. C., Gao, X., Schwarzschild, M. A., & Ascherio, A. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171175 · Cited by 21

Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women

Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677

Association of Coffee Consumption and Prediagnostic Caffeine Metabolites With Incident Parkinson Disease in a Population-Based Cohort

Zhao, Y., Lai, Y., Konijnenberg, H., Huerta, J. M., Vinagre‐Aragón, A., Sabin, J., Hansen, J., Petrova, D., Sacerdote, C., Zamora‐Ros, R., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209201 · Cited by 49

Caffeine and risk of Parkinson’s disease in a large cohort of men and women

Palacios, N., Gao, X., McCullough, M. L., Schwarzschild, M. A., Shah, R., Gapstur, S., & Ascherio, A. (2012) · Movement Disorders · doi:10.1002/mds.25076 · Cited by 185